Vascular endothelial growth factor in chronic rat allograft nephropathy

Transplant Immunology

Volumn 19, Issue 2, 2008, Pages 136-144

  Malmström, Niina K ^a   Kallio, Erkki A ^a,b   Rintala, Jukka M ^a   Nykänen, Antti I ^a   Räisänen Sokolowski, Anne K ^a   Paavonen, Timo ^a,c   Lemström, Karl B ^a,b   Koskinen, Petri K ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Chronic allograft nephropathy; Chronic rejection; PTK787; Vascular endothelial growth factor

Indexed keywords

CYCLOSPORIN A; INTRALIPID; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VATALANIB;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; GLOMERULUS; GRAFT RECIPIENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; GRAFT REJECTION; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; PHTHALAZINES; PROTEIN KINASE INHIBITORS; PYRIDINES; RATS; SIGNAL TRANSDUCTION; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 43949131074     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.01.009     Document Type: Article

References (41)

1. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 1 (1999 Jan) 9-22
2. Zachary I., Mathur A., Yla-Herttuala S., and Martin J. Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 20 6 (2000 Jun) 1512-1520
3. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., and Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 8 (1996 Apr 15) 3336-3343
4. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P.C., et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172 6 (1990 Dec 1) 1535-1545
5. Grosskreutz C.L., Anand-Apte B., Duplaa C., Quinn T.P., Terman B.I., Zetter B., et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 58 2 (1999 Sep) 128-136
6. Wang H., and Keiser J.A. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83 8 (1998 Oct 19) 832-840
7. Celletti F.L., Hilfiker P.R., Ghafouri P., and Dake M.D. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. J Am Coll Cardiol 37 8 (2001 Jun 15) 2126-2130
8. Brown L.F., Berse B., Tognazzi K., Manseau E.J., Van de Water L., Senger D.R., et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42 6 (1992 Dec) 1457-1461
9. Simon M., Rockl W., Hornig C., Grone E.F., Theis H., Weich H.A., et al. Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites. J Am Soc Nephrol 9 6 (1998 Jun) 1032-1044
10. Noguchi K., Yoshikawa N., Ito-Kariya S., Inoue Y., Hayashi Y., Ito H., et al. Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9 10 (1998 Oct) 1815-1825
11. Shulman K., Rosen S., Tognazzi K., Manseau E.J., and Brown L.F. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7 5 (1996 May) 661-666
12. Honkanen E., von Willebrand E., Koskinen P., Teppo A.M., Tornroth T., Ruutu M., et al. Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course. Am J Kidney Dis 42 6 (2003 Dec) 1139-1148
13. Cha D.R., Kim N.H., Yoon J.W., Jo S.K., Cho W.Y., Kim H.K., et al. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int Suppl 77 (2000 Sep) S104-S112
14. Wada Y., Morioka T., Oyanagi-Tanaka Y., Yao J., Suzuki Y., Gejyo F., et al. Impairment of vascular regeneration precedes progressive glomerulosclerosis in anti-Thy 1 glomerulonephritis. Kidney Int 61 2 (2002 Feb) 432-443
15. Kang D.H., Joly A.H., Oh S.W., Hugo C., Kerjaschki D., Gordon K.L., et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12 7 (2001 Jul) 1434-1447
16. Ostendorf T., Kunter U., Eitner F., Loos A., Regele H., Kerjaschki D., et al. VEGF(165) mediates glomerular endothelial repair. J Clin Invest 104 7 (1999 Oct) 913-923
17. Kang D.H., Hughes J., Mazzali M., Schreiner G.F., and Johnson R.J. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12 7 (2001 Jul) 1448-1457
18. Lemstrom K.B., Krebs R., Nykanen A.I., Tikkanen J.M., Sihvola R.K., Aaltola E.M., et al. Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation 105 21 (2002 May 28) 2524-2530
19. Raisky O., Nykanen A.I., Krebs R., Hollmen M., Keranen M.A., Tikkanen J.M., et al. VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts. Arterioscler Thromb Vasc Biol 27 4 (2007 Apr) 819-825
20. Tambur A.R., Pamboukian S., Costanzo M.R., and Heroux A. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J Heart Lung Transplant 25 6 (2006 Jun) 690-698
21. Pilmore H.L., Eris J.M., Painter D.M., Bishop G.A., and McCaughan G.W. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 67 6 (1999 Mar 27) 929-933
22. Cao G., Lu Y., Gao R., Xin Y., Teng D., Wang J., et al. Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection. Transplant Proc 38 7 (2006 Sep) 1998-2000
23. Lemos F.B., Mol W.M., Roodnat J.I., Uitterlinden A., Ijzermans J.N., Weimar W., et al. The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation. Transplantation 79 9 (2005 May 15) 1221-1225
24. Wood J.M., Bold G., Buchdunger E., Cozens R., Ferrari S., Frei J., et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 60 8 (2000 Apr 15) 2178-2189
25. Savikko J., Taskinen E., and Von Willebrand E. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy. Transplantation 75 8 (2003 Apr 27) 1147-1153
26. Isoniemi H., Taskinen E., and Hayry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 58 11 (1994 Dec 15) 1195-1198
27. Minchenko A., Bauer T., Salceda S., and Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71 3 (1994 Sep) 374-379
28. Marti H.H., and Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A 95 26 (1998 Dec 22) 15809-15814
29. Ben-Av P., Crofford L.J., Wilder R.L., and Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 372 1 (1995 Sep 18) 83-87
30. Li J., Perrella M.A., Tsai J.C., Yet S.F., Hsieh C.M., Yoshizumi M., et al. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem 270 1 (1995 Jan 6) 308-312
31. Cohen T., Nahari D., Cerem L.W., Neufeld G., and Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271 2 (1996 Jan 12) 736-741
32. Ryuto M., Ono M., Izumi H., Yoshida S., Weich H.A., Kohno K., et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271 45 (1996 Nov 8) 28220-28228
33. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269 9 (1994 Mar 4) 6271-6274
34. Finkenzeller G., Sparacio A., Technau A., Marme D., and Siemeister G. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15 6 (1997 Aug 7) 669-676
35. Freeman M.R., Schneck F.X., Gagnon M.L., Corless C., Soker S., Niknejad K., et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 55 18 (1995 Sep 15) 4140-4145
36. Melter M., Reinders M.E., Sho M., Pal S., Geehan C., Denton M.D., et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96 12 (2000 Dec 1) 3801-3808
37. Hellstrom M., Kalen M., Lindahl P., Abramsson A., and Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126 14 (1999 Jun) 3047-3055
38. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 10 (2002 Sep 3) 1199-1204
39. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408 6808 (2000 Nov 2) 92-96
40. Reinders M.E., Fang J.C., Wong W., Ganz P., and Briscoe D.M. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection. Transplantation 76 1 (2003 Jul 15) 224-230
41. Ozdemir B.H., Ozdemir F.N., Haberal N., Emiroglu R., Demirhan B., and Haberal M. Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection. Am J Transplant 5 4 Pt 1 (2005 Apr) 766-774